Because the study cohort consisted of only 13 patients, multivariable analysis to assess whether ITGB8 expression had independent predictive value beyond standard clinical risk factors (stage, grade, CIS status, multiplicity, and tumor size) was not statistically feasible. The gene discussed is ITGB8; the disease is in situ carcinoma.